Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Clinical Microbiology
|
January 1, 1996
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay
J M Pawlotsky, A Bastie, C Pellet, et al.
Journal of Medical Virology
|
April 29, 1998
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C
J M Pawlotsky, M Pellerin, M Bouvier, et al.
Gastroenterology
|
January 1, 1997
Histopathologic impact of GB virus C infection on chronic hepatitis C
M P Bralet, F Roudot-Thoraval, J M Pawlotsky, et al.
The Journal of Infectious Diseases
|
July 1, 1996
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C
J M Pawlotsky, F Roudot-Thoraval, A Bastie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2013
The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011
A Lièvre, P Artru, M Guiu, et al.
Journal of Virological Methods
|
June 25, 1999
Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays
J M Pawlotsky, M Martinot-Peignoux, J D Poveda, et al.
Journal of Hepatology
|
December 22, 1999
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions
C Hézode, C Cazeneuve, O Coué, et al.
Journal of Hepatology
|
August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group
F Degos, V Daurat, S Chevret, et al.
Journal of Hepatology
|
April 16, 1998
Characteristics of patients with dual infection by hepatitis B and C viruses
J P Zarski, B Bohn, A Bastie, et al.
Journal of Hepatology
|
November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group
S Naveau, A Balian, F Degos, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Clinical Microbiology
|
January 1, 1996
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay
J M Pawlotsky, A Bastie, C Pellet, et al.
Journal of Medical Virology
|
April 29, 1998
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C
J M Pawlotsky, M Pellerin, M Bouvier, et al.
Gastroenterology
|
January 1, 1997
Histopathologic impact of GB virus C infection on chronic hepatitis C
M P Bralet, F Roudot-Thoraval, J M Pawlotsky, et al.
The Journal of Infectious Diseases
|
July 1, 1996
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C
J M Pawlotsky, F Roudot-Thoraval, A Bastie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2013
The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011
A Lièvre, P Artru, M Guiu, et al.
Journal of Virological Methods
|
June 25, 1999
Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays
J M Pawlotsky, M Martinot-Peignoux, J D Poveda, et al.
Journal of Hepatology
|
December 22, 1999
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions
C Hézode, C Cazeneuve, O Coué, et al.
Journal of Hepatology
|
August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group
F Degos, V Daurat, S Chevret, et al.
Journal of Hepatology
|
April 16, 1998
Characteristics of patients with dual infection by hepatitis B and C viruses
J P Zarski, B Bohn, A Bastie, et al.
Journal of Hepatology
|
November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group
S Naveau, A Balian, F Degos, et al.
Page
of 3